Search results
Factor XIIa, Human
Research studies or protocols where a source of highly purified human factor XIIa is required.
Protein Z, Human
ZYMUTEST HIA, IgGAM Screening
Assessment of the risk to develop HIT/HITT, in patients treated with heparins (unfractionated or LMWH): presence of antibodies is a risk indicator for development of HIT/HITT. Clinical suspicion of HIT during heparin therapy.
ZYMUTEST vWF:CBA (Collagen Binding Assay)
Diagnosis of von Willebrand disease (vWD). Assay of vWF:CBA in clinical samples, as a disease marker or as an indicator for cardiovascular diseases.
BIOPHEN Factor IX (1)
Assay proposed for the measurement of factor IX activity in research applications.
LIAPHEN™ Protein C
Quantitative determination of protein C antigen in human citrated plasma.
S-2251™
Chromogenic substrate for plasmin and streptokinase-activated plasminogen.
Isotonic Sample Diluent
This in vitro diagnostic product is intended for professional use in laboratory.
BIOPHEN Antithrombin LRT (anti-(h)-Xa, Liquid Reagent Technology)
Diagnosis of congenital or acquired antithrombin deficiencies.
BIOPHEN Antithrombin LRT (anti-(h)-Xa, Liquid Reagent Technology)
Diagnosis of congenital or acquired antithrombin deficiencies.